GRI Bio, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Hertz Walter Marc | Chief Executive Officer | Award / Grant | 385,510 | — | — | 385,510 | Apr 21, 2023 |
| Agro Albert | Chief Medical Officer | Award / Grant | 172,189 | — | — | 172,189 | Apr 21, 2023 |
| Chaturvedi Vipin | Chief Scientific Officer | Award / Grant | 172,189 | — | — | 172,189 | Apr 21, 2023 |
| Thorell Marella | — | Other | 28,517 | — | — | 9,506 | Dec 13, 2022 |
| Thorell Marella | — | Award / Grant | 38,023 | — | — | 38,023 | Jul 1, 2022 |
| Kelly Leanne M. | Chief Financial Officer | Purchase | 1,085 | $4.05 | $4,394 | 4,742 | Jun 2, 2021 |
| Payne Joseph E | — | Purchase | 6,800 | $4.50 | $30,600 | 17,500 | May 25, 2021 |
| Baker David Charles | Chief Executive Officer | Other | 7,843 | $6.40 | $50,195 | 7,843 | Feb 12, 2021 |
| SALMON Pharma GmbH | — | Other | 47,063 | $6.40 | $301,203 | 47,063 | Feb 12, 2021 |
| Ammer Richard | — | Other | 47,063 | $6.40 | $301,203 | 47,063 | Feb 12, 2021 |